Kasyanov Evgeny, Yakovleva Yana, Khobeysh Maria, Gerasimchuk Ekaterina, Mazo Galina
Department of Social Neuropsychiatry, V. M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russia.
Department of Integrative Pharmaco-Psychotherapy, V. M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russia.
Clin Pract Epidemiol Ment Health. 2025 May 23;21:e17450179372815. doi: 10.2174/0117450179372815250516102324. eCollection 2025.
Differing conceptualizations of recurrent and persistent depression in the Diagnostic and Statistical Manual of Mental Disorders (DSM) and International Classification of Diseases (ICD) lead to diagnostic inconsistencies. This scoping review analyzed epidemiological studies on the lifetime prevalence of recurrent and persistent depression in the general population.
Following PRISMA-ScR guidelines, we searched MEDLINE and the Russian Science Citation Index without time or language restrictions. Inclusion criteria were original epidemiological studies of the general population reporting lifetime prevalence of recurrent or persistent depression, using DSM-III/IV/5 or ICD-9/10/11 criteria.
Only three studies on recurrent depression were identified - from Switzerland, the USA, and Hungary - showing a consistent lifetime prevalence of 10.3% to 10.5%. In contrast, major depressive disorder had a lifetime prevalence of 1.5 to 2.5 times higher in these studies. Dysthymia and persistent depression showed lifetime prevalences ranging from 1.1% to 6.4% and 1.6% to 18%, respectively. Women represented about two-thirds of cases of both recurrent and persistent depression.
The underrepresentation of recurrent depression may stem from the DSM's dominant influence in psychiatric diagnostics. Our findings highlight the need for refined diagnostic criteria and more comprehensive epidemiological studies that separately identify recurrent and persistent depression.
《精神疾病诊断与统计手册》(DSM)和《国际疾病分类》(ICD)中对复发性和持续性抑郁症的概念界定不同,导致诊断不一致。本范围综述分析了关于普通人群中复发性和持续性抑郁症终生患病率的流行病学研究。
遵循PRISMA-ScR指南,我们检索了MEDLINE和俄罗斯科学引文索引,没有时间或语言限制。纳入标准是对普通人群进行的原始流行病学研究,报告使用DSM-III/IV/5或ICD-9/10/11标准的复发性或持续性抑郁症的终生患病率。
仅确定了三项关于复发性抑郁症的研究——分别来自瑞士、美国和匈牙利——显示终生患病率一致,为10.3%至10.5%。相比之下,在这些研究中,重度抑郁症的终生患病率高出1.5至2.5倍。恶劣心境障碍和持续性抑郁症的终生患病率分别为1.1%至6.4%和1.6%至18%。复发性和持续性抑郁症患者中约三分之二为女性。
复发性抑郁症代表性不足可能源于DSM在精神科诊断中的主导影响。我们的研究结果强调需要完善诊断标准,并开展更全面的流行病学研究,以分别识别复发性和持续性抑郁症。